EMA wants warning of blood clots with low platelet count for Johnson and Johnson vaccine
The Hindu
The safety committee also ‘concluded that these events should be listed as very rare side effects of the vaccine’.
Eight cases of serious, unusual blood clots associated with low levels of blood platelets, one of which was fatal, have been seen in the U.S. after administration of On April 20, European Medicines Agency’s safety committee (PRAC) based on these cases “concluded that a warning about unusual blood clots with low blood platelets should be added to the product information for COVID-19 Vaccine Janssen”. The safety committee also “concluded that these events should be listed as very rare side effects of the vaccine”. As of 13 April 2021, over seven million people had received the vaccine in the U.S. In a press release, the EMA said that it found “with low blood platelets” following administration of Johnson and Johnson vaccine. On April 13, the U.S. called for a pause in Johnson & Johnson vaccine use when six cases of a rare blood-clotting disorder were seen in the vaccinated people.More Related News